Triple-negative breast cancers (TNBCs) are an aggressive subtype of breast cancer constituting 10–15% of all breast cancers and are defined by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.